CytoMed Therapeutics Limited
CytoMed Therapeutics Limited is a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star), incorporated in 2018.
Listing updated
About CytoMed Therapeutics Limited
CytoMed Therapeutics Limited is a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star), incorporated in 2018. The company is focused on engineering more affordable cellular cancer therapies to identify and attack a multitude of solid and hematological cancers.
CytoMed is translating its patent-pending technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based “off-the-shelf” immunotherapeutics for a wide range of cancers. It also generates induced pluripotent stem cells (iPSCs) and develops them into cellular therapeutics using its proprietary technologies for its customers.
- Category
- Biotechnology company
- Location
- Singapore
- Website
- cytomed.sg
Summary written with AI from public business data. Disclaimer
Products & services
- iPSC-γδ NKT Cell Technology (gdNKT Therapy)
- CAR-γδ T Cell Technology (CTM-N2D Therapy)
- Induced pluripotent stem cell (iPSC) generation and cellular therapeutic development
Tap a product to find other suppliers of it.
Location
Quick facts
- Business name
- CytoMed Therapeutics Limited
- What it supplies
- CytoMed Therapeutics Limited is listed under Biotechnology company.
- Category
- Biotechnology company
- Location
- Singapore
- Listed products and services
- iPSC-γδ NKT Cell Technology (gdNKT Therapy), CAR-γδ T Cell Technology (CTM-N2D Therapy), Induced pluripotent stem cell (iPSC) generation and cellular therapeutic development. (Summarised with AI from public business data.)
- How to contact
- Phone, website and an enquiry form on this page.
- Listing last updated